The fifth edition of the STM report provides an in-depth review of current issues and recent trends within the scientific and scholarly publishing industry.
Increasing quality and transparency of preclinical data: an opportunity for publication professionals?
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Significance testing and p values are widely used in medical publications, but just how meaningful are they?
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
Join other medical, science, and publications professionals worldwide to #PressforProgress on #IWD2018 and beyond.
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.
Missed ISMPP EU 2018? Read our meeting report to get up to speed!
Online Registration Until January 3, 2018! Medical publication professionals from the pharmaceutical industry, medical communication agencies, journals, academia, etc., are all welcome to participate in the 2018 European Meeting of … Continue Reading Calling All Medical Publication Professionals – Join Us at the 2018 European ISMPP Meeting
Although most scientists understand the importance of publishing all study data, it remains a fact that articles describing data that do not confirm the author’s hypothesis are less likely to … Continue Reading Celebrating the positives in negative results
Recently, F1000Research published the first article of their new Registered Report initiative. The publisher is the first to go a step further with this publication format, combining the Registered Report … Continue Reading Registered Reports: enhancing transparency and reproducibility in scientific publication
In a position paper published in The Leadership Quarterly earlier this year, Professor John Antonakis described factors that he believes are stifling the production of useful scientific research. In response to … Continue Reading ‘Bad science’ and how new ideas in scientific publishing can combat it